For life science founders
Investor-ready starts here.
Zonvic helps life science founders strengthen investor conviction through a structured investment evaluation framework, powered by AI.
The Zonvic Difference
Most AI tools review a pitch deck using general-purpose prompts.
Zonvic evaluates every company using the Zonvic Investment Framework, a structured methodology informed by practical experience evaluating early-stage life science companies and designed to reflect how experienced life science investors assess investment opportunities.
Instead of generating generic feedback, Zonvic evaluates scientific credibility, commercial opportunity, development strategy, fundraising readiness, and overall investment thesis using a consistent, investor-oriented framework.
The underlying AI model is only the reasoning engine.
The framework is what makes Zonvic unique.
From Zero to Conviction
Every startup begins at zero.
The journey to successful fundraising is not about creating a more persuasive pitch. It is about systematically building investor conviction through stronger science, better evidence, thoughtful strategy, and clear communication.
Zonvic exists to help life science founders make that journey. Our mission is to reduce uncertainty before founders ever step into an investor meeting — by combining AI with investor-oriented thinking to identify weaknesses, anticipate due diligence questions, strengthen the investment narrative, and improve the overall quality of the company.
Zonvic is not a pitch deck beautifier.
It is an AI copilot that helps founders think like experienced investors.
What an investor looks for, before an investor looks.
Zonvic helps founders move from uncertainty to conviction by providing AI-powered reviews across the areas investors evaluate most closely.
Scientific rationale
Whether the underlying science supports the claims being made, and where it doesn't yet.
Therapeutic strategy
The coherence of indication choice, development path, and sequencing decisions.
Competitive positioning
How the company's approach compares to existing and emerging alternatives.
Investment risks
The technical, clinical, regulatory, and commercial risks investors will weigh first.
Fundraising readiness
Whether the evidence on hand matches the ambition of the raise being planned.
Likely investor questions
The specific due diligence questions this company should expect, and be ready for.
Evidence gaps
What data, experiments, or validation would most strengthen the case being made.
Investment narrative
Whether the story connects science, strategy, and market into one coherent thesis.
The platform is built to feel like an experienced life science investor reviewing your company — not a tool that simply summarizes your pitch deck.
A review that reads like diligence.
Every report is structured the way an investor would organize their own notes after a first meeting.
Sample review
Preclinical oncology therapeutics company
Strengths
- Differentiated mechanism with supporting in vivo data
- Experienced founding team with prior exits in the space
- Clearly defined initial indication
Diligence questions to expect
- How does efficacy translate across the two animal models shown?
- What is the freedom-to-operate position relative to the closest competitor?
- What specifically de-risks the path to an IND?
Evidence gap
No dose-response data has been generated yet. Investors evaluating this stage of company will likely treat this as the primary open question before committing.
Illustrative excerpt. Your review reflects your own company, evidence, and strategy.
AI Pitch Deck Review
Start with a free read on where you stand, then go deeper when you're ready to iterate.
Free Review
Free
- Executive Summary
- Investor Readiness Score
- Top Three Strengths
- Top Three Concerns
- Highest Priority Improvements
Zonvic Pro
Free during launchFree$29/month
- Comprehensive Investor Review
- Zonvic Investment Readiness Score
- Scientific & Technical Evaluation
- Commercial Opportunity Analysis
- Team Assessment
- Development Strategy Evaluation
- Fundraising Readiness Evaluation
- Slide-by-Slide Feedback
- Missing Information Checklist
- Likely Investor Questions
- Prioritized Actionable Recommendations
- Compare Up To Three Deck Versions
- PDF Report
Zonvic Investment Readiness Score
Every Zonvic Pro review ends with an overall readiness score plus a category breakdown — tracked automatically across one project with up to three deck versions, so you can watch it improve as you iterate.
One Project. Three Deck Versions.
Start Zonvic ProThe value of Zonvic is the Zonvic Investment Framework, not the model behind it. Every review is automatically orchestrated across a combination of AI providers for quality and cost — there's no model to pick. You're buying a proprietary, investor-grade methodology, not access to a particular AI.
How founders work with Zonvic.
Most founders move through this progression at their own pace — start free, go deeper when it's useful.
Upload Pitch Deck
Submit your deck for an investor-oriented AI review.
Free Review
Get a readiness score, high-level strengths and concerns, and an executive summary.
Zonvic Pro
Go deeper with the full Investment Readiness Score, and iterate across up to three deck versions.
Zonvic does not promise a successful raise.
It helps you make better decisions and communicate with more clarity — so that when you do sit down with investors, the conviction is already there.